261 related articles for article (PubMed ID: 33849589)
1. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model.
Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q
Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589
[TBL] [Abstract][Full Text] [Related]
2. RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma.
Wang W; Huang Z; Sheng Y; Zhao J; Shahnazi K; Zhang Q; Jiang G
Radiother Oncol; 2020 Mar; 144():30-36. PubMed ID: 31710941
[TBL] [Abstract][Full Text] [Related]
3. RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model.
Zhang L; Wang W; Hu J; Lu J; Kong L
Radiat Oncol; 2020 Dec; 15(1):277. PubMed ID: 33302998
[TBL] [Abstract][Full Text] [Related]
4. Brainstem NTCP and Dose Constraints for Carbon Ion RT-Application and Translation From Japanese to European RBE-Weighted Dose.
Dale JE; Molinelli S; Vischioni B; Vitolo V; Bonora M; Magro G; Mairani A; Hasegawa A; Ohno T; Dahl O; Valvo F; Fossati P
Front Oncol; 2020; 10():531344. PubMed ID: 33330020
[TBL] [Abstract][Full Text] [Related]
5. Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results.
Grosshagauer S; Fossati P; Schafasand M; Carlino A; Poljanc K; Radakovits T; Stock M; Hug E; Georg P; Pelak M; Góra J
Radiother Oncol; 2022 Oct; 175():73-78. PubMed ID: 35952977
[TBL] [Abstract][Full Text] [Related]
6. Validation of the relative biological effectiveness of active-energy scanning carbon-ion radiotherapy on a commercial treatment planning system with a microdosimetic kinetic model.
Wang W; Sun W; Shen H; Zhao J
Radiat Oncol; 2023 May; 18(1):82. PubMed ID: 37198685
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity study of the microdosimetric kinetic model parameters for carbon ion radiotherapy.
Dahle TJ; Magro G; Ytre-Hauge KS; Stokkevåg CH; Choi K; Mairani A
Phys Med Biol; 2018 Nov; 63(22):225016. PubMed ID: 30418940
[TBL] [Abstract][Full Text] [Related]
8. Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems.
Molinelli S; Magro G; Mairani A; Matsufuji N; Kanematsu N; Inaniwa T; Mirandola A; Russo S; Mastella E; Hasegawa A; Tsuji H; Yamada S; Vischioni B; Vitolo V; Ferrari A; Ciocca M; Kamada T; Tsujii H; Orecchia R; Fossati P
Radiother Oncol; 2016 Aug; 120(2):307-12. PubMed ID: 27394694
[TBL] [Abstract][Full Text] [Related]
9. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
Gillmann C; Jäkel O; Schlampp I; Karger CP
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
[TBL] [Abstract][Full Text] [Related]
10. Rectum Dose Constraints for Carbon Ion Therapy: Relative Biological Effectiveness Model Dependence in Relation to Clinical Outcomes.
Choi K; Molinelli S; Russo S; Mirandola A; Fiore MR; Vischioni B; Fossati P; Petrucci R; Turturici I; Dale JE; Valvo F; Ciocca M; Mairani A
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877802
[TBL] [Abstract][Full Text] [Related]
11. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
[TBL] [Abstract][Full Text] [Related]
12. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation.
Bridges D; Kawamura H; Kanai T
PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520
[TBL] [Abstract][Full Text] [Related]
13. Calibration and evaluation of the relative biological effectiveness for carbon-ion radiotherapy in a new relative to a clinically applied treatment planning system.
Wang W; Huang Z; Sun W; Wang X; Zhao J; Shen H
Radiat Oncol; 2022 Dec; 17(1):219. PubMed ID: 36587224
[TBL] [Abstract][Full Text] [Related]
14. Radiobiological issues in prospective carbon ion therapy trials.
Fossati P; Matsufuji N; Kamada T; Karger CP
Med Phys; 2018 Nov; 45(11):e1096-e1110. PubMed ID: 30421806
[TBL] [Abstract][Full Text] [Related]
15. Optic nerve constraints for carbon ion RT at CNAO - Reporting and relating outcome to European and Japanese RBE.
Dale JE; Molinelli S; Vitolo V; Vischioni B; Bonora M; Magro G; Pettersen HES; Mairani A; Hasegawa A; Dahl O; Valvo F; Fossati P
Radiother Oncol; 2019 Nov; 140():175-181. PubMed ID: 31310888
[TBL] [Abstract][Full Text] [Related]
16. RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV.
Gillmann C; Jäkel O; Karger CP
Radiother Oncol; 2019 Dec; 141():234-238. PubMed ID: 31522880
[TBL] [Abstract][Full Text] [Related]
17. RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes.
Molinelli S; Bonora M; Magro G; Casale S; Dale JE; Fossati P; Hasegawa A; Mirandola A; Ronchi S; Russo S; Preda L; Valvo F; Orecchia R; Ciocca M; Vischioni B
Radiother Oncol; 2019 Dec; 141():227-233. PubMed ID: 31522881
[TBL] [Abstract][Full Text] [Related]
18. Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy.
Steinsträter O; Grün R; Scholz U; Friedrich T; Durante M; Scholz M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):854-60. PubMed ID: 22483698
[TBL] [Abstract][Full Text] [Related]
19. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.
Zhou C; Jones B; Moustafa M; Yang B; Brons S; Cao L; Dai Y; Schwager C; Chen M; Jaekel O; Chen L; Debus J; Abdollahi A
Clin Transl Radiat Oncol; 2019 Jan; 14():25-32. PubMed ID: 30511024
[TBL] [Abstract][Full Text] [Related]
20. How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy.
Molinelli S; Magro G; Mairani A; Allajbej A; Mirandola A; Chalaszczyk A; Imparato S; Ciocca M; Fiore MR; Orlandi E
Radiother Oncol; 2021 Oct; 163():209-214. PubMed ID: 34506829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
